8-K: InspireMD Stockholders Re-Elect Directors and Ratify Auditors at 2025 Annual Meeting

InspireMD, Inc. announced the successful re-election of Michael Berman and Scott R. Ward to its Board of Directors and the ratification of Kesselman & Kesselman as its independent registered public accounting firm for the 2025 fiscal year at its annual meeting.

Summary

• InspireMD, Inc. held its 2025 annual meeting of stockholders on June 3, 2025.
• As of the record date, April 15, 2025, there were 30,635,356 shares of common stock issued and outstanding and entitled to vote.
• A quorum was present with 20,478,807 shares, or 66.84%, represented in person or by proxy.
• Stockholders re-elected Michael Berman and Scott R. Ward as Class 2 directors for a three-year term.
• Michael Berman received 12,429,779 'For' votes and 248,915 'Withheld' votes.
• Scott R. Ward received 12,447,235 'For' votes and 231,459 'Withheld' votes.
• Stockholders ratified the appointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limited, as the company's independent registered public accounting firm for the 2025 fiscal year.
• The auditor ratification received 20,308,180 'For' votes, 164,980 'Against' votes, and 5,647 'Abstain' votes.

Sentiment

Score: 5

Explanation: The document reports on routine corporate governance matters (annual meeting results, director re-election, auditor ratification) which are generally neutral in sentiment as they represent standard operational procedures without indicating significant positive or negative shifts in company performance or strategy.

Positives

• The company successfully held its annual meeting with a strong quorum of 66.84% of outstanding shares represented.
• Both nominated directors, Michael Berman and Scott R. Ward, were re-elected, indicating continuity and stockholder confidence in the current board composition.
• The appointment of the independent registered public accounting firm was ratified by a significant majority of votes, ensuring financial oversight continuity.

Future Outlook

The document does not provide specific forward-looking statements or guidance beyond the re-election of directors for a three-year term and the ratification of auditors for the 2025 fiscal year.

Management Comments

• Craig Shore, Chief Financial Officer, signed the report on behalf of InspireMD, Inc.

Industry Context

This 8-K filing reports on routine corporate governance matters, specifically the outcomes of an annual stockholder meeting. Such events are standard practice across all publicly traded companies and do not inherently reflect broader industry trends, but rather the company's adherence to regulatory and governance requirements.

Corporate Governance

Stakeholder Impact

• Shareholders: Exercised their voting rights to elect directors and ratify auditors, ensuring their representation and oversight in corporate governance.
• Board of Directors: The re-election of Michael Berman and Scott R. Ward provides continuity and stability to the board's leadership.
• Auditors: Kesselman & Kesselman's ratification confirms their role in providing independent financial auditing services for the upcoming fiscal year.

Next Steps

• Re-elected Class 2 directors, Michael Berman and Scott R. Ward, will serve for a term of three years or until their respective successors are elected and qualified.
• Kesselman & Kesselman will serve as the company's independent registered public accounting firm for the 2025 fiscal year.

Key Dates

Keywords

InspireMD, Annual Meeting, Stockholders, Director Election, Auditor Ratification, Corporate Governance, Voting Results, SEC Filing, 8-K